Eviti
Date | Investors | Amount | Round |
---|---|---|---|
N/A | $5.1m | Seed | |
N/A | Acquisition | ||
Total Funding | €4.6m |
Related Content
Recent News about Eviti
EditEviti, a product of NantHealth, is a digital oncology treatment library that provides a comprehensive and independent collection of evidence-based treatment options. The platform includes nearly 1,200 proven treatment options covering all modalities for more than 120 cancer types. Eviti serves healthcare providers, oncologists, and clinical decision-makers by integrating with electronic health records (EHR) systems or functioning as a standalone web-based application. The business operates in the healthcare technology market, focusing on oncology care. Eviti's business model revolves around subscription fees and integration services, generating revenue by offering access to its extensive treatment library and clinical decision support tools. The platform aims to enhance the treatment decision process, improve patient outcomes, and streamline oncology care workflows.
Keywords: oncology, treatment library, evidence-based, cancer types, healthcare providers, clinical decision support, EHR integration, oncology care, subscription model, NantHealth.